Jennifer Michaelson, Chief Scientific Officer at Cullinan Therapeutics, Inc. (CGEM), sold 16,000 shares at $16.33 ($261K) on 2024-07-05, disclosed to the SEC on 2024-07-09.
Scheduled sale ($261k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.33 | 8,000 | $131K | 50.0% |
| 2 | $16.33 | 8,000 | $131K | 50.0% |
| Total | $16.33 avg | 16,000 | $261K | 100% |
| Filing → |
| CGEM | SELL | 2026-07-07 | $143K | — | Filing → |
| CGEM | SELL | 2026-05-06 | $117K | — | Filing → |
| CGEM | SELL | 2026-03-09 | $125K | — | Filing → |